# Denosumab and MRI Breast Imaging

> **NCT02613416** · PHASE2 · COMPLETED · sponsor: **Alison Stopeck** · enrollment: 42 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** Denosumab

## Key facts

- **NCT ID:** NCT02613416
- **Lead sponsor:** Alison Stopeck
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-11
- **Primary completion:** 2021-08-20
- **Final completion:** 2021-08-20
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2024-08-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02613416

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02613416, "Denosumab and MRI Breast Imaging". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02613416. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*